FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures

समान संसाधन

• FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
  द्वारा: Brown, P, और अन्य
  प्रकाशित: (2015)
• Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
  द्वारा: Wong, K, और अन्य
  प्रकाशित: (2014)
• Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
  द्वारा: Wong, K, और अन्य
  प्रकाशित: (2014)
• The significance of FOXP1 in diffuse large B-cell lymphoma
  द्वारा: Gascoyne, D, और अन्य
  प्रकाशित: (2016)
• Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D
  द्वारा: Gascoyne, D, और अन्य
  प्रकाशित: (2016)